384 related articles for article (PubMed ID: 25501551)
1. Micro-RNA 21 inhibition of SMAD7 enhances fibrogenesis via leptin-mediated NADPH oxidase in experimental and human nonalcoholic steatohepatitis.
Dattaroy D; Pourhoseini S; Das S; Alhasson F; Seth RK; Nagarkatti M; Michelotti GA; Diehl AM; Chatterjee S
Am J Physiol Gastrointest Liver Physiol; 2015 Feb; 308(4):G298-312. PubMed ID: 25501551
[TBL] [Abstract][Full Text] [Related]
2. High circulatory leptin mediated NOX-2-peroxynitrite-miR21 axis activate mesangial cells and promotes renal inflammatory pathology in nonalcoholic fatty liver disease.
Alhasson F; Seth RK; Sarkar S; Kimono DA; Albadrani MS; Dattaroy D; Chandrashekaran V; Scott GI; Raychoudhury S; Nagarkatti M; Nagarkatti P; Diehl AM; Chatterjee S
Redox Biol; 2018 Jul; 17():1-15. PubMed ID: 29660503
[TBL] [Abstract][Full Text] [Related]
3. NADPH Oxidase-Derived Peroxynitrite Drives Inflammation in Mice and Human Nonalcoholic Steatohepatitis via TLR4-Lipid Raft Recruitment.
Das S; Alhasson F; Dattaroy D; Pourhoseini S; Seth RK; Nagarkatti M; Nagarkatti PS; Michelotti GA; Diehl AM; Kalyanaraman B; Chatterjee S
Am J Pathol; 2015 Jul; 185(7):1944-57. PubMed ID: 25989356
[TBL] [Abstract][Full Text] [Related]
4. Sparstolonin B attenuates early liver inflammation in experimental NASH by modulating TLR4 trafficking in lipid rafts via NADPH oxidase activation.
Dattaroy D; Seth RK; Das S; Alhasson F; Chandrashekaran V; Michelotti G; Fan D; Nagarkatti M; Nagarkatti P; Diehl AM; Chatterjee S
Am J Physiol Gastrointest Liver Physiol; 2016 Apr; 310(7):G510-25. PubMed ID: 26718771
[TBL] [Abstract][Full Text] [Related]
5. Exogenous PP2A inhibitor exacerbates the progression of nonalcoholic fatty liver disease via NOX2-dependent activation of miR21.
Albadrani M; Seth RK; Sarkar S; Kimono D; Mondal A; Bose D; Porter DE; Scott GI; Brooks B; Raychoudhury S; Nagarkatti M; Nagarkatti P; Jule Y; Diehl AM; Chatterjee S
Am J Physiol Gastrointest Liver Physiol; 2019 Oct; 317(4):G408-G428. PubMed ID: 31393787
[TBL] [Abstract][Full Text] [Related]
6. Epigallocatechin gallate attenuated non-alcoholic steatohepatitis induced by methionine- and choline-deficient diet.
Ding Y; Sun X; Chen Y; Deng Y; Qian K
Eur J Pharmacol; 2015 Aug; 761():405-12. PubMed ID: 25967348
[TBL] [Abstract][Full Text] [Related]
7. Fluvastatin attenuates hepatic steatosis-induced fibrogenesis in rats through inhibiting paracrine effect of hepatocyte on hepatic stellate cells.
Chong LW; Hsu YC; Lee TF; Lin Y; Chiu YT; Yang KC; Wu JC; Huang YT
BMC Gastroenterol; 2015 Feb; 15():22. PubMed ID: 25886887
[TBL] [Abstract][Full Text] [Related]
8. TGF-β signaling is activated in patients with chronic HBV infection and repressed by SMAD7 overexpression after successful antiviral treatment.
Argentou N; Germanidis G; Hytiroglou P; Apostolou E; Vassiliadis T; Patsiaoura K; Sideras P; Germenis AE; Speletas M
Inflamm Res; 2016 May; 65(5):355-65. PubMed ID: 26856334
[TBL] [Abstract][Full Text] [Related]
9. Upregulation of miR21 and repression of Grhl3 by leptin mediates sinusoidal endothelial injury in experimental nonalcoholic steatohepatitis.
Pourhoseini S; Seth RK; Das S; Dattaroy D; Kadiiska MB; Xie G; Michelotti GA; Nagarkatti M; Diehl AM; Chatterjee S
PLoS One; 2015; 10(2):e0116780. PubMed ID: 25658689
[TBL] [Abstract][Full Text] [Related]
10. Deletion of Smad4 reduces hepatic inflammation and fibrogenesis during nonalcoholic steatohepatitis progression.
Qin G; Wang GZ; Guo DD; Bai RX; Wang M; Du SY
J Dig Dis; 2018 May; 19(5):301-313. PubMed ID: 29696816
[TBL] [Abstract][Full Text] [Related]
11. CYP2J2 overexpression attenuates nonalcoholic fatty liver disease induced by high-fat diet in mice.
Chen G; Xu R; Zhang S; Wang Y; Wang P; Edin ML; Zeldin DC; Wang DW
Am J Physiol Endocrinol Metab; 2015 Jan; 308(2):E97-E110. PubMed ID: 25389366
[TBL] [Abstract][Full Text] [Related]
12. Osteopontin is a proximal effector of leptin-mediated non-alcoholic steatohepatitis (NASH) fibrosis.
Coombes JD; Choi SS; Swiderska-Syn M; Manka P; Reid DT; Palma E; Briones-Orta MA; Xie G; Younis R; Kitamura N; Della Peruta M; Bitencourt S; Dollé L; Oo YH; Mi Z; Kuo PC; Williams R; Chokshi S; Canbay A; Claridge LC; Eksteen B; Diehl AM; Syn WK
Biochim Biophys Acta; 2016 Jan; 1862(1):135-44. PubMed ID: 26529285
[TBL] [Abstract][Full Text] [Related]
13. NADPH oxidase is not an essential mediator of oxidative stress or liver injury in murine MCD diet-induced steatohepatitis.
dela Peña A; Leclercq IA; Williams J; Farrell GC
J Hepatol; 2007 Feb; 46(2):304-13. PubMed ID: 17157947
[TBL] [Abstract][Full Text] [Related]
14. Folic acid supplementation attenuates high fat diet induced hepatic oxidative stress via regulation of NADPH oxidase.
Sarna LK; Wu N; Wang P; Hwang SY; Siow YL; O K
Can J Physiol Pharmacol; 2012 Feb; 90(2):155-65. PubMed ID: 22309437
[TBL] [Abstract][Full Text] [Related]
15. Role of Smad proteins in the regulation of NF-kappaB by TGF-beta in colon cancer cells.
Grau AM; Datta PK; Zi J; Halder SK; Beauchamp RD
Cell Signal; 2006 Jul; 18(7):1041-50. PubMed ID: 16288847
[TBL] [Abstract][Full Text] [Related]
16. The xanthine oxidase inhibitor febuxostat suppresses development of nonalcoholic steatohepatitis in a rodent model.
Nakatsu Y; Seno Y; Kushiyama A; Sakoda H; Fujishiro M; Katasako A; Mori K; Matsunaga Y; Fukushima T; Kanaoka R; Yamamotoya T; Kamata H; Asano T
Am J Physiol Gastrointest Liver Physiol; 2015 Jul; 309(1):G42-51. PubMed ID: 25999428
[TBL] [Abstract][Full Text] [Related]
17. Disruption of Smad4 impairs TGF-β/Smad3 and Smad7 transcriptional regulation during renal inflammation and fibrosis in vivo and in vitro.
Meng XM; Huang XR; Xiao J; Chung AC; Qin W; Chen HY; Lan HY
Kidney Int; 2012 Feb; 81(3):266-79. PubMed ID: 22048127
[TBL] [Abstract][Full Text] [Related]
18. The expression dynamics of transforming growth factor-β/Smad signaling in the liver fibrosis experimentally caused by Clonorchis sinensis.
Yan C; Wang L; Li B; Zhang BB; Zhang B; Wang YH; Li XY; Chen JX; Tang RX; Zheng KY
Parasit Vectors; 2015 Feb; 8():70. PubMed ID: 25649869
[TBL] [Abstract][Full Text] [Related]
19. Salidroside alleviates oxidative stress in the liver with non- alcoholic steatohepatitis in rats.
Yang ZR; Wang HF; Zuo TC; Guan LL; Dai N
BMC Pharmacol Toxicol; 2016 Apr; 17():16. PubMed ID: 27075663
[TBL] [Abstract][Full Text] [Related]
20. Pioglitazone attenuates hepatic inflammation and fibrosis in phosphatidylethanolamine N-methyltransferase-deficient mice.
van der Veen JN; Lingrell S; Gao X; Quiroga AD; Takawale A; Armstrong EA; Yager JY; Kassiri Z; Lehner R; Vance DE; Jacobs RL
Am J Physiol Gastrointest Liver Physiol; 2016 Apr; 310(7):G526-38. PubMed ID: 26797396
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
